BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 TransactivationHaobin Chen, David S. Schrump, Lisa Gesumaria et al.|Molecular Cancer Research|2022Cited by 29
mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancerAnju Kumari, Haobin Chen, Crystal McKnight et al.|JCI Insight|2023Cited by 20
BET Inhibitors Target the SCLC-N subtype Small Cell Lung Cancer by Blocking NEUROD1 TransactivationHaobin Chen, David S. Shrump, Lisa Gesumaria et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 5
mTOR Inhibition Overcomes RSK3-mediated Resistance to BET Inhibitors in Small Cell Lung CancerAnju Kumari, Haobin Chen, Lisa Gesumaria et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2
Abstract 5328: mTOR inhibitor enhances anti-tumor effect of BET bromodomain inhibitor in small cell lung cancerAnju Kumari, Haobin Chen, Lisa Gesumaria et al.|Cancer Research|2020Cited by 0